US Patent Issued to GENMONT BIOTECH INCORPORATION on July 1 for "Lactobacillus reuteri GMNL-263 for improving hypertension and its compositions thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,364, issued on July 1, was assigned to GENMONT BIOTECH INCORPORATION (Tainan, Taiwan).

"Lactobacillus reuteri GMNL-263 for improving hypertension and its compositions thereof" was invented by Yi-Hsing Chen (Tainan, Taiwan) and Wan-Hua Tsai (Kaohsiung, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Present invention discloses a Lactobacillus composition comprising Lactobacillus reuteri GMNL-263 which is a strain of heat-killed dead bacteria and has the effect of lowering blood pressure by inhibition of proinflammatory cytokine IL-1Beta and enhancement the growth of Bifidobacterium, and said Lactobacillus composition is a pharmaceutical composit...